Could the combination of Nab-paclitaxel plus gemcitabine salvage metastatic pancreatic adenocarcinoma after folfirinox failure? A single institutional retrospective analysis. [electronic resource]
Producer: 20180723Description: e26-e28 p. digitalISSN:- 2210-741X
- Adenocarcinoma -- drug therapy
- Aged
- Albumins -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Camptothecin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Drug Combinations
- Female
- Fluorouracil -- administration & dosage
- Humans
- Irinotecan
- Leucovorin -- administration & dosage
- Male
- Middle Aged
- Organometallic Compounds -- administration & dosage
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Paclitaxel -- administration & dosage
- Pancreatic Neoplasms -- drug therapy
- Retrospective Studies
- Risk Factors
- Treatment Failure
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.